Stryker deal "hiccups" drag Inion sales growth down
This article was originally published in Clinica
Executive Summary
The share price of Finnish biodegradable implant maker Inion plummeted by more than 50% on May 11 2005 after the company admitted it would be unlikely to meet the triple-digit full-year sales growth forecast it made in March.